Skip to main content
Log in

Taking the profit out of biomedical research tools

  • Patents
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

Abstract

A National Institutes of Health proposal will restrict the licensing of Federally funded biomedical research tools for commercial gain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Marshall, E. Science 278, 212–213 (1997); Adler, R.G. The New Biologist 2, 495–497 (1990).

    Article  CAS  Google Scholar 

  2. 35 USC §§ 200 et seq.

  3. Intellectual Property Rights and Research Tools in Molecular Biology. Summary of a study held at the National Academy of Sciences, Feb. 15–16, 1996.

  4. Report of the NIH Working Group on Research Tools, p. 4, June 4, 1998.

  5. See Eisenberg, R. 5 Risk: Health Safety & Environment 163 (1994). Professor Eisenberg has also argued in favor of a research exemption from the patent laws. See Eisenberg, R. 56 U. Chi. L. Rev. 1017 (1989).

    Google Scholar 

  6. See NIH Proposed Guidelines for Recipients of NIH Research Grants and Contracts on Obtaining and Disseminating Biomedical Research Resources; Request for Comments, 64 Fed. Reg., No. 100, May 25, 1999, pp. 28205–28209.

  7. Id. at 28206.

  8. Id.

  9. Id. at 28205, fn.1.

  10. Id.

  11. Id. at 28207.

  12. Id.

  13. Id. at 28206.

  14. Id.

  15. National Academy Study, Chapter 5, Case Studies, "Protein and DNA sequencing instruments: Research tools to which strong patent protection promoted broad access.".

  16. Id.

  17. Id.

  18. Undocumented conversation with Dr. Leroy Hood .

  19. 35 USC § 203.

  20. 35 USC § 203(1)(a) through (d).

  21. 35 USC § 202(a)(ii).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Flores, M. Taking the profit out of biomedical research tools. Nat Biotechnol 17, 819–820 (1999). https://doi.org/10.1038/11774

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/11774

  • Springer Nature America, Inc.

This article is cited by

Navigation